Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity

被引:4
作者
Rana, Harvesh Kumar [1 ,2 ]
Singh, Amit Kumar [1 ,3 ]
Kumar, Ramesh [1 ,4 ]
Pandey, Abhay K. [1 ]
机构
[1] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India
[2] Feroze Gandhi Postgrad Coll, Dept Zool, Raebareli 229001, India
[3] BMK Govt Girls Coll, Dept Bot, Balod 491226, Chhattisgarh, India
[4] Cent Univ Punjab, Dept Biochem, Bathinda 151401, Punjab, India
关键词
Tuberculosis; Drug-resistance; Hepatoprotective; Natural products; Liver injury;
D O I
10.1007/s00210-023-02679-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium which causes tuberculosis (TB). TB control programmes are facing threats from drug resistance. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb strains need longer and more expensive treatment with many medications resulting in more adverse effects and decreased chances of treatment outcomes. The World Health Organization (WHO) has emphasised the development of not just new individual anti-TB drugs, but also novel medication regimens as an alternative treatment option for the drug-resistant Mtb strains. Many plants, as well as marine creatures (sponge; Haliclona sp.) and fungi, have been continuously used to treat TB in various traditional treatment systems around the world, providing an almost limitless supply of active components. Natural products, in addition to their anti-mycobacterial action, can be used as adjuvant therapy to increase the efficacy of conventional anti-mycobacterial medications, reduce their side effects, and reverse MDR Mtb strain due to Mycobacterium's genetic flexibility and environmental adaptation. Several natural compounds such as quercetin, ursolic acid, berberine, thymoquinone, curcumin, phloretin, and propolis have shown potential anti-mycobacterial efficacy and are still being explored in preclinical and clinical investigations for confirmation of their efficacy and safety as anti-TB medication. However, more high-level randomized clinical trials are desperately required. The current review provides an overview of drug-resistant TB along with the latest anti-TB medications, drug-induced hepatotoxicity and oxidative stress. Further, the role and mechanisms of action of first and second-line anti-TB drugs and new drugs have been highlighted. Finally, the role of natural compounds as anti-TB medication and hepatoprotectants have been described and their mechanisms discussed.
引用
收藏
页码:1251 / 1273
页数:23
相关论文
共 46 条
  • [11] Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity
    Baniasadi, Shadi
    Eftekhari, Parivash
    Tabarsi, Payam
    Fahimi, Fanak
    Raoufy, Mohammad Reza
    Masjedi, Mohammad Reza
    Velayati, Ali Akbar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (10) : 1235 - 1238
  • [12] Drug Resistance of Human Immunodeficiency Virus and Overcoming it by Natural Products
    Hupfeld, Julia
    Efferth, Thomas
    IN VIVO, 2009, 23 (01): : 1 - 6
  • [13] Evaluation of the physicians' approach to the diagnosis and treatment of patients with antituberculosis drug-induced hepatotoxicity
    Thongraung, Wilawan
    Sittidach, Maneerat
    Khwansuwan, Panatda
    Sariyasuntorn, Kanitha
    Wongsampan, Sirinart
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (06) : 1119 - 1125
  • [14] Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients
    Tostmann, Alma
    van den Boogaard, Jossy
    Semvua, Hadija
    Kisonga, Riziki
    Kibiki, Gibson S.
    Aarnoutse, Rob E.
    Boeree, Martin J.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (02) : 268 - 272
  • [15] Protective Effect of Caffeic Acid Phenethyl Ester on Antituberculosis Drug-Induced Hepatotoxicity in Rats
    Aliosmanoglu, Cigdem
    Erbi, Halil
    Aliosmanoglu, Ibrahim
    Turkoglu, Mehmet Akif
    Ulger, Burak Veli
    Turkoglu, Ahmet
    Yuksel, Hatice
    INTERNATIONAL SURGERY, 2017, 102 (9-10) : 473 - 478
  • [16] NAT2 polymorphism and clinical factors that increased antituberculosis drug-induced hepatotoxicity
    Noor, Nur Farhana Mohamed
    Salleh, Mohd Zaki
    Zim, Mohd Arif Mohd
    Abu Bakar, Zamzurina
    Noorizhab, Mohd Nur Fakhruzzaman
    Zakaria, Noor Izyani
    Lailanor, Muhammad Imran
    Teh, Lay Kek
    PHARMACOGENOMICS, 2022, 23 (09) : 531 - 541
  • [17] Hepatoprotective Evaluation of Trapa natans against Drug-induced Hepatotoxicity of Antitubercular Agents in Rats
    Hussain, Talib
    Subaiea, Gehad M.
    Firdous, Hina
    PHARMACOGNOSY MAGAZINE, 2018, 14 (54) : 180 - 185
  • [18] The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity
    Ho, Hsin-Tien
    Wang, Teng-Hsu
    Hsiong, Cheng-Huei
    Perng, Wann-Cherng
    Wang, Ning-Chi
    Huang, Tien-Yu
    Jong, Yuh-Jyh
    Lu, Po-Liang
    Hu, Oliver Yoa-Pu
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (04) : 200 - 207
  • [19] Drug-induced Hepatotoxicity of Anti-tuberculosis Drugs and Their Serum Levels
    Jeong, Ina
    Park, Jong-Sun
    Cho, Young-Jae
    Yoon, Ho Il
    Song, Junghan
    Lee, Choon-Taek
    Lee, Jae-Ho
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (02) : 167 - 172
  • [20] Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity
    Magalhaes Coca, Natalia Saldanha
    Oliveira, Marcelo Silva
    Voieta, Izabela
    de Figueiredo Antunes, Carlos Mauricio
    Lambertucci, Jose Roberto
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 (06) : 624 - 628